Objective Approximately one third of epileptic children do not achieve complete seizure improvement. Zonisamide is a new antiepileptic drug which is effective as adjunctive therapy in treatment of intractable partial seizures. The purpose of the current study was to evaluate the effectiveness, safety, and tolerability of Zonisamide in epileptic children
Background. Comparative study of antiepileptic drugs allows to make the optimal choice in therapy.Th...
Introduction: About 70 million people worldwide are estimated to suffer from epilepsy. Despite a lar...
OBJECTIVE: To evaluate the efficacy and safety of adjunctive zonisamide (ZNS) therapy in Korean adul...
AbstractThis study examined the efficacy and safety of zonisamide as monotherapy in pediatric patien...
PURPOSE: This study investigated the efficacy and safety of zonisamide (ZNS) adjunctive therapy in c...
none13PURPOSE: To report on the first multicenter Italian experience with zonisamide as an add-on dr...
AbstractPostmarketing data about the effectiveness of zonisamide in childhood epilepsy was collected...
To retrospectively evaluate the efficacy of zonisamide as adjunctive therapy in the treatment of ref...
Objective To evaluate the efficacy and safety of zonisamide (ZNS) as adjunctive therapy in patients ...
PURPOSE: To report on the first multicenter Italian experience with zonisamide as an add-on drug fo...
AbstractPurposeTo evaluate the effectiveness and tolerability of zonisamide in children with epileps...
Zonisamide is a novel anticonvulsant that is structurally and mechanistically unique, compared with ...
ObjectiveThe Lennox-Gastaut syndrome (LGS: the triad of intractable seizures of various types, a slo...
Zonisamide is a benzisoxazole derivative, chemically unrelated to other antiepileptic drugs, that ap...
AbstractZonisamide is an antiepilepsy drug (AED) with both sodium and calcium channel-blocking prope...
Background. Comparative study of antiepileptic drugs allows to make the optimal choice in therapy.Th...
Introduction: About 70 million people worldwide are estimated to suffer from epilepsy. Despite a lar...
OBJECTIVE: To evaluate the efficacy and safety of adjunctive zonisamide (ZNS) therapy in Korean adul...
AbstractThis study examined the efficacy and safety of zonisamide as monotherapy in pediatric patien...
PURPOSE: This study investigated the efficacy and safety of zonisamide (ZNS) adjunctive therapy in c...
none13PURPOSE: To report on the first multicenter Italian experience with zonisamide as an add-on dr...
AbstractPostmarketing data about the effectiveness of zonisamide in childhood epilepsy was collected...
To retrospectively evaluate the efficacy of zonisamide as adjunctive therapy in the treatment of ref...
Objective To evaluate the efficacy and safety of zonisamide (ZNS) as adjunctive therapy in patients ...
PURPOSE: To report on the first multicenter Italian experience with zonisamide as an add-on drug fo...
AbstractPurposeTo evaluate the effectiveness and tolerability of zonisamide in children with epileps...
Zonisamide is a novel anticonvulsant that is structurally and mechanistically unique, compared with ...
ObjectiveThe Lennox-Gastaut syndrome (LGS: the triad of intractable seizures of various types, a slo...
Zonisamide is a benzisoxazole derivative, chemically unrelated to other antiepileptic drugs, that ap...
AbstractZonisamide is an antiepilepsy drug (AED) with both sodium and calcium channel-blocking prope...
Background. Comparative study of antiepileptic drugs allows to make the optimal choice in therapy.Th...
Introduction: About 70 million people worldwide are estimated to suffer from epilepsy. Despite a lar...
OBJECTIVE: To evaluate the efficacy and safety of adjunctive zonisamide (ZNS) therapy in Korean adul...